Cefoperazone is a new cephalosporin with a very wide spectrum of activity, including activity against Pseudomonas aeruginosa. It has less activity on enterococci and Acinetobacter. Of the 459 selected bacterial strains tested in this study, only 1.5% (7 strains and 6 genera) had minimum inhibitory concentrations of >128 ,ug/ml. 
Cefoperazone is a new parenteral piperazine cephalosporin antimicrobial agent that has been demonstrated to have a wide spectrum of antimicrobial activity against medically important bacteria (1, (7) (8) (9) (10) (11) 18) . Preliminary studies indicate that the drug has very favorable pharmacological properties (2, 5, 12, 17) . Therefore, it is possible that this drug could, in the near future, be approved for the treatment of infected patients.
If this antimicrobial agent is approved for therapeutic use, it would be advantageous to have already determined the methods that could be used for antimicrobial susceptibility tests with cefoperazone. Since the agar disk diffusion test (14) is the routine method used in most clinical microbiology laboratories, we have investigated various test parameters to determine whether a disk diffusion test with cefoperazone is feasible and, if so, to establish the most efficacious disk drug concentration and interpretive zone diameter breakpoints. The following is a report of those studies.
MATERIALS AND METHODS
Bacteria. The 459 bacteria used in this study are listed in Table 1 . They were selected without regard to the frequency with which they are routinely found in clinical microbiology laboratories, but were chosen to represent typical microbial species found in clinical practice, including both cephalothin-susceptible and cephalothin-resistant strains. These were recent clinical isolates, but were supplemented with stock strains when necessary to achieve the desired species representation. Many of these organisms were selected from those strains sent to one laboratory (C.T.) by six collaborators (A. L. Barry, Sacramento, Calif.; P. C. Fuchs and R. N. Jones, Portland, Ore; T. L. Gavan, Cleveland, Ohio; E. H. Gerlach, Wichita, Kans.; and H. M. Sommers, Chicago, Ill.) from five geographic locations. The selected set of strains was then distributed to each participant.
Disk diffusion tests. The four cefoperazone disk potencies (30, 50, 75, and 100 p.g) used in this study were prepared in one laboratory (C.T.) by adding the appropriate concentration of the antimicrobial, contained in 25 ,ul of diluent, to a 6-mm filter paper disk. The disks were dried and stored at -70°C or below in the presence of silica gel desiccant containing an indicator, and the disks were shipped frozen to the other participants. The disk diffusion tests were performed by the standard method of the National Committee for Clinical Laboratory Standards (14) . Standard diffusion curves were performed as described by Barry (3) .
Dilution antimicrobial susceptibility tests. The minimum inhibitory concentrations (MICs) for these organisms were determined by the broth microdilution method as described in the National Committee for Clinical Laboratory Standards standard for dilution tests (15) . The microdilution trays containing cationsupplemented Mueller-Hinton broth (15) were prepared as a single lot by one manufacturer (Prepared Media Laboratory, Portland, Ore.). They were shipped frozen to each participant, and maintained there at -20°C or below until just before inoculation with the test strains (4, 6) .
Statistical methods. The regression coefficients were obtained by computer, using the method of least squares. The tabulation of zones of inhibition and MICs by organism, as well as by the error rate bounding method (13) , was also performed by computer, using appropriate programs.
These tests were performed collaboratively in different laboratories, by using the same protocol, as described previously (4, 6, 18) . Comparability of results 
RESULTS
A list of the 459 bacteria used in this study and a comparison of their susceptibilities to cefoperazone and cephalothin are shown in Table 1 . The greater spectrum of activity of cefoperazone is demonstrated by the facts that 59.5% of the strains were resistant to cephalothin at -16 ,ug/ ml and only 9.4% were resistant to cefoperazone at the same concentration. Organisms highly resistant to cefoperazone (MIC, .128 p,g/ml)
were distributed among six genera of gramnegative bacilli. If one examines the cefoperazone MIC90 values for all strains, however, they can be stratified as shown in Fig. 1 . Most of the enteric bacilli (except Serratia) and Staphylococcus aureus are very susceptible to cefoperazone. Pseudomonas aeruginosa and Serratia are slightly less susceptible but are still well within the susceptible range. Acinetobacter and enterococci are the least inhibited by cefoperazone. On the other hand, the cephalothin MIC90 values in Fig. 2 show the markedly decreased activity of this reference drug against most of the organisms (except S. aureus) at the dosages usually administered clinically.
An analysis of the cross-resistance between cefoperazone, cephalothin, cefamandole, and cefoxitin is shown in Table 2 . These data indicate the necessity of having a separate cefoperazone disk and that presently available cephalosporin disks cannot serve as a class disk for this new cephalosporin.
Mean zone diameters were also determined for five reference strains, using disks with concentrations of 5 to 200 ,ug (Table 3 ). These data, as well as the other diffusion data, indicated that the cefoperazone diffusion characteristics would permit development of a disk diffusion test.
The standard diffusion curves (not shown) for cefoperazone and four reference organisms indicate a greater antimicrobial activity of cefoperazone against S. aureus, Escherichia coli, and P. aeruginosa than against Streptococcus faecalis. These data also showed that the cefoperazone rate of diffusion is similar to that of cefamandole.
Regression statistics for 30-, 50-, 75-, and 100-,ug disks are presented in Table 4 , and the scattergrams for the 30-and 75-,ug disks are shown in Fig. 3 On the basis of these data, we selected the disk drug concentrations and zone diameter interpretive breakpoints shown in Table 5 4 and 256 ,ug/ml. ----------------------------------- and Pseudomonas cepacia; major errors-Acinetobacter anitratus, P. aeruginosa, S. aureus (methicillin resistant), and Streptococcusfaecalis. Error rates were determined by the method of Metzler and DeHaan (13) . No particular organisms were involved more than others since seven different species gave the seven discrepant results. With the 75-,g disk, 5% of the orga- Fig. 5) (8, 9) .
The organisms shown in Table 6 are recommended for control of disk diffusion tests (14) . These organisms were tested 20 separate times with the four different cefoperazone disks and the 30-,ug cephalothin disk. The modal MICs and ranges of disk inhibitory zone diameters obtained are presented (Table 6 ).
DISCUSSION
Until recent years, cephalothin was the class disk which represented all cephalosporins in agar disk diffusion antimicrobial susceptibility tests. But when cefoxitin and cefamandole were approved for clinical use it became apparent that the cephalothin disk could no longer represent these two new beta-lactam antimicrobials, and a 30-tig disk for each was thus approved and recommended for use in clinical laboratories (14) . An analysis of cross-resistance (Table 2) confirmed the decision to use these two new disks and also showed that cefoperazone must also have its own disk. The recommendations set forth in Table 5 were determined after taking into consideration the antimicrobial spectrum of activity of the new cephalosporin, its pharma- . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . cology, its agar diffusion characteristics, its molecular characteristics, and statistical evaluation of the in vitro data.
The very wide spectrum of activity of cefoperazone on bacteria commonly associated with clinical infections is shown by the MIC%0 values depicted in Fig. 1 . Of the organisms likely to be tested by disk diffusion, cefoperazone has a marked activity on Enterobacteriaceae and S. aureus (8, 9) , although the activity on the latter species is not as great as that of cephalothin. Unlike other available cephalosporins, cefoperazone also is active on most P. aeruginosa strains, with MICs well below the achievable serum levels. Acinetobacter and enterococci fall into an intermediate level of susceptibility.
Cefoperazone also has activity on some species that are not usually tested by the disk diffusion method. It is very active against Haemophilus influenzae and Neisseria species (1), streptococci other than serogroup D (8, 9, 18) , and anaerobes (7) (8) (9) (10) .
A comparison of the spectra of antimicrobial activity of cefoperazone with that of cefotaxime and moxalactam, two other new broad-spectrum beta-lactam antibiotics that have been recently studied (4, 6) , showed that they are similar in many ways. The major difference is that cefoperazone has greater activity on P. aeruginosa and streptococci (8, 9, 11, 18) . It has minimal activity on Campylobacter sp., but none of the three is particularly active on this species (M. Miller, J. Swenson, and C. Thomsberry, manuscript in preparation). Although all three cephalosporins are essentially resistant to beta-lactamases, it is probable that cefotaxime and moxalactam are more stable than cefoperazone (16) .
The serum levels of cefoperazone achieved with the usual 2-g dose given as a bolus, or over periods of 30 or 60 min, are shown in Fig. 1 (2, 5, 12, 17) . It appears that in most cases the drug could be given twice daily and the levels would be adequate to inhibit the enteric bacilli, staphylococci, anaerobes, non-enterococcal streptococci, and many P. aeruginosa strains. In addition, the levels in the first 6 h would probably be adequate to suppress many of the Acinetobacter and enterococci. The superior pharmacological properties of cefoperazone compared with an older cephalosporin such as cephalothin can be seen by comparing Fig. 1 and 2 . At 6 h, the concentration of cephalothin is minimal and would essentially obviate twice daily or thrice daily dosing. Greater serum levels are also obtained with cefoperazone than with cefotaxime and, to lesser extent, moxalactam (2, (4) (5) (6) 12) . Because of these pharmacological differences, we have chosen a susceptible breakpoint of s32 ,ug/ml (resistant, >64 ,ug/ml) for cefoperazone, compared with susceptible breakpoints of <8 ,ug/ml (moderately susceptible, 16 to 32 ,ug/ml; resistant, >32 p,g/ml) for cefotaxime and moxalactam (4, 6) . These MIC breakpoints are obviously important when choosing a disk drug concentration for the drugs. (Table 3) showed that the zone diameters gradually increased as the disk antimicrobial concentration increased. When regression lines were plotted on four of these disk concentrations (30, 50, 75, and 100 ,ug), they were essentially parallel. This is also reflected in the regression statistics in that the slopes do not significantly differ (Table 4) .
Molecular weight also contributes to the diffusion characteristics of an antimicrobial agent and ultimately may be a factor in the selection of the disk to be used in a diffusion test. When the molecular weights of the sodium salts of cefoperazone, moxalactam, and cefotaxime are compared, they decrease in that order (667.6, 564.5, and 477.5). Cefoperazone thus has 28.2% fewer active molecules per unit weight than does cefotaxime, with moxalactam in between. By comparison, the molecular weight of cefamandole is 512.5, and that of cephalothin is 418.4. The higher molecular weight is yet another factor which contributed to our selection of a higher disk concentration for cefoperazone than for the other cephalosporin drugs.
The regression lines and regression statistics (Table 4) , in addition to the zone diameters themselves ( Table 3 ), indicated that the diffusion rate was adequate for one to assume that a disk diffusion test could be used to discriminate susceptible and resistant strains at MIC breakpoints of 32 ptg/ml. When these data were examined by the error rate bounding method of Metzler and DeHaan (13) and the distribution of zone diameters for the population of bacteria used in the study were compared with MICs, we concluded that the breakpoints given in Table 5 
